Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FSEZU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,676
Award facts
- Contract value 100% obligated
- $11,676.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Kisqali 400 mg daily dose tablets (42-count units) valued at $11,676.19. This firm fixed price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products to support federal military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Kisqali, a brand-name oncology medication, exemplifies the company's role as a critical vendor in the federal medical supply chain supporting Defense Health Agency and broader military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FSEZU?
SPE2DB25FSEZU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FSEZU worth?
The government has obligated $11,676 on SPE2DB25FSEZU.
Is contract SPE2DB25FSEZU an order under another contract?
Yes. SPE2DB25FSEZU is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSEZU competed?
The extent of competition for SPE2DB25FSEZU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award